Montelukast Sodium Tablet, Chewable
Product Images NDC 62175-205

5 FDA label images from Lannett Company, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Montelukast Sodium (NDC 62175-205). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Lannett Company, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Montelukast Sodium Chewable Tablets 1)

Figure 1 (Montelukast Sodium Chewable Tablets 1)
A line graph depicting change in height (cm) over weeks on treatment for three groups: Montelukast Sodium 5 mg, Beclomethasone 336 mcg, and Placebo. The x-axis represents weeks on treatment ranging from -19 to 56 weeks, and the y-axis shows change in height in centimeters. The graph includes data points and trend lines for each treatment group.*
FDA Label Image

Chemical Structure (Montelukast Sodium Chewable Tablets 2)

Chemical Structure (Montelukast Sodium Chewable Tablets 2)
Chemical structure of Montelukast Sodium, showing its molecular arrangement including aromatic rings, a chlorine atom, sulfur atom, and sodium carboxylate group.*
FDA Label Image

Figure 2 (Montelukast Sodium Chewable Tablets 3)

Figure 2 (Montelukast Sodium Chewable Tablets 3)
A line graph showing mean percent change from baseline over weeks in treatment, comparing Montelukast Sodium and placebo. The x-axis represents weeks in treatment (0 to 15), including a washout period. The y-axis shows mean percent change from baseline. Montelukast Sodium demonstrates a higher increase compared to placebo throughout the treatment period.*
FDA Label Image

4 mg 30 Count (Montelukast Sodium Chewable Tablets 4)

4 mg 30 Count (Montelukast Sodium Chewable Tablets 4)
Montelukast Sodium 4 mg chewable tablets label for oral use, distributed by Lannett Company, Inc. The label indicates the product is for pediatric patients aged 2-5 years and contains 30 tablets. Storage instructions and dosage guidance references are included on the label.*
FDA Label Image

5 mg 30 Count (Montelukast Sodium Chewable Tablets 5)

5 mg 30 Count (Montelukast Sodium Chewable Tablets 5)
Montelukast Sodium 5 mg chewable tablets label for pediatric patients aged 6-14 years. The label indicates 30 tablets per package, prescription only, distributed by Lannett Company, Inc., Philadelphia, PA. Storage instructions and dosage information references are included, along with a barcode and revision date.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.